SurgePays (SURG) Competitors $2.94 -0.08 (-2.65%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$2.93 -0.01 (-0.34%) As of 07/25/2025 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock SURG vs. ZIMV, SMTI, BWAY, TCMD, CV, CVRX, MGRM, SKIN, SGHT, and TLSIShould you be buying SurgePays stock or one of its competitors? The main competitors of SurgePays include ZimVie (ZIMV), Sanara MedTech (SMTI), Brainsway (BWAY), Tactile Systems Technology (TCMD), CapsoVision (CV), CVRx (CVRX), Monogram Orthopaedics (MGRM), Beauty Health (SKIN), Sight Sciences (SGHT), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry. SurgePays vs. Its Competitors ZimVie Sanara MedTech Brainsway Tactile Systems Technology CapsoVision CVRx Monogram Orthopaedics Beauty Health Sight Sciences TriSalus Life Sciences SurgePays (NASDAQ:SURG) and ZimVie (NASDAQ:ZIMV) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings. Do analysts recommend SURG or ZIMV? SurgePays presently has a consensus target price of $9.00, suggesting a potential upside of 206.12%. ZimVie has a consensus target price of $17.00, suggesting a potential downside of 9.19%. Given SurgePays' stronger consensus rating and higher possible upside, equities analysts clearly believe SurgePays is more favorable than ZimVie.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SurgePays 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00ZimVie 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Is SURG or ZIMV more profitable? ZimVie has a net margin of -4.40% compared to SurgePays' net margin of -136.37%. ZimVie's return on equity of 5.53% beat SurgePays' return on equity.Company Net Margins Return on Equity Return on Assets SurgePays-136.37% -206.01% -153.67% ZimVie -4.40%5.53%2.84% Which has higher valuation and earnings, SURG or ZIMV? ZimVie has higher revenue and earnings than SurgePays. ZimVie is trading at a lower price-to-earnings ratio than SurgePays, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurgePays$60.88M0.99-$45.73M-$2.79-1.05ZimVie$449.75M1.16-$25.83M-$0.71-26.37 Which has more volatility and risk, SURG or ZIMV? SurgePays has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.07, indicating that its share price is 107% more volatile than the S&P 500. Do institutionals and insiders hold more shares of SURG or ZIMV? 6.9% of SurgePays shares are owned by institutional investors. Comparatively, 95.6% of ZimVie shares are owned by institutional investors. 30.5% of SurgePays shares are owned by insiders. Comparatively, 3.0% of ZimVie shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media prefer SURG or ZIMV? In the previous week, ZimVie had 11 more articles in the media than SurgePays. MarketBeat recorded 15 mentions for ZimVie and 4 mentions for SurgePays. SurgePays' average media sentiment score of 0.76 beat ZimVie's score of 0.53 indicating that SurgePays is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SurgePays 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ZimVie 3 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryZimVie beats SurgePays on 11 of the 17 factors compared between the two stocks. Get SurgePays News Delivered to You Automatically Sign up to receive the latest news and ratings for SURG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SURG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SURG vs. The Competition Export to ExcelMetricSurgePaysINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket Cap$61.64M$18.58B$28.91B$9.50BDividend YieldN/A2.76%3.02%4.01%P/E Ratio-1.0577.0934.2320.05Price / Sales0.9971.921,715.6089.38Price / CashN/A94.1238.3858.56Price / Book3.878.767.795.87Net Income-$45.73M$341.62M$782.91M$258.55M7 Day Performance1.03%2.45%0.81%3.73%1 Month Performance-4.55%11.59%6.12%11.75%1 Year Performance-2.00%55.50%52,641.07%18.03% SurgePays Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SURGSurgePays3.2901 of 5 stars$2.94-2.6%$9.00+206.1%-2.0%$61.64M$60.88M-1.0540ZIMVZimVie0.5308 of 5 stars$18.76+122.3%$16.33-12.9%-13.8%$235.03M$449.75M-26.421,770News CoverageAnalyst UpgradeHigh Trading VolumeSMTISanara MedTech2.0107 of 5 stars$26.28-0.1%$49.50+88.4%-20.7%$233.84M$86.67M-19.6160Positive NewsBWAYBrainsway2.7702 of 5 stars$12.09flat$14.25+17.9%+53.3%$228.47M$41.02M60.45120Positive NewsTCMDTactile Systems Technology3.6431 of 5 stars$9.66+1.5%$16.00+65.6%-18.3%$221.32M$292.98M14.641,037Positive NewsCVCapsoVisionN/A$4.45-2.2%N/AN/A$210.87MN/A0.0090Negative NewsGap DownCVRXCVRx3.0268 of 5 stars$8.29+3.6%$14.50+74.9%-12.5%$208.58M$51.29M-3.80160Positive NewsMGRMMonogram Orthopaedics1.0841 of 5 stars$5.69+0.4%$5.40-5.1%+126.3%$202.35M$370K-12.6428Gap UpSKINBeauty Health0.2077 of 5 stars$1.66+4.4%$1.42-14.7%-1.6%$200.33M$334.30M-4.051,030Gap UpSGHTSight Sciences1.408 of 5 stars$3.43-2.0%$3.93+14.7%-56.5%$180.93M$79.87M-3.50210Upcoming EarningsTLSITriSalus Life Sciences2.849 of 5 stars$4.57-0.7%$10.75+135.2%-20.1%$174.06M$29.43M-4.08106News CoveragePositive News Related Companies and Tools Related Companies ZimVie Competitors Sanara MedTech Competitors Brainsway Competitors Tactile Systems Technology Competitors CapsoVision Competitors CVRx Competitors Monogram Orthopaedics Competitors Beauty Health Competitors Sight Sciences Competitors TriSalus Life Sciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SURG) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SurgePays, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SurgePays With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
